Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: COLONIC NEOPLASMS - GENETICS , . Treffer: 26
2019
Washetine, K; Heeke, S; Ribeyre, C; Bourreau, C; Normand, C; Blons, H; Laurent-Puig, P; Mulot, C; Clermont, D; David, M; Clément, B; Dagher, G; Hofman, P
DNAshell Protects DNA Stored at Room Temperature for Downstream Next-Generation Sequencing Studies.
Biopreserv Biobank. 2019; 17(4): 352-354.
Doi: 10.1089/bio.2018.0129
Web of Science
PubMed
FullText
FullText_MUG
2018
Zhong, Q; Wagner, U; Kurt, H; Molinari, F; Cathomas, G; Komminoth, P; Barman-Aksözen, J; Schneider-Yin, X; Rey, JP; Vassella, E; Rogel, U; Diebold, J; McKee, T; Jochum, W; Kashofer, K; Hofman, P; Zischka, M; Moch, H; Rechsteiner, M; Wild, PJ
Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
Pathol Res Pract. 2018; 214(7):957-963
Doi: 10.1016/j.prp.2018.05.020
Web of Science
PubMed
FullText
FullText_MUG
2017
Stotz, M; Herzog, SA; Pichler, M; Smolle, M; Riedl, J; Rossmann, C; Bezan, A; Stöger, H; Renner, W; Berghold, A; Gerger, A
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Anticancer Res. 2017; 37(4):2011-2018
Doi: 10.21873/anticanres.11545
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Bohanes, P; Yang, D; Loupakis, F; LaBonte, MJ; Gerger, A; Ning, Y; Lenz, C; Lenz, F; Wakatsuki, T; Zhang, W; Benhaim, L; El-Khoueiry, A; El-Khoueiry, R; Lenz, HJ
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Pharmacogenomics J. 2015; 15(3):226-234
Doi: 10.1038/tpj.2014.66
Web of Science
PubMed
FullText
FullText_MUG
Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG)
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830
Doi: 10.1016/j.ebiom.2015.06.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sebio, A; Gerger, A; Matsusaka, S; Yang, D; Zhang, W; Stremitzer, S; Stintzing, S; Sunakawa, Y; Yamauchi, S; Ning, Y; Fujimoto, Y; Ueno, M; Lenz, HJ
Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer.
Pharmacogenet Genomics. 2015; 25(1):30-37
Doi: 10.1097/FPC.0000000000000101
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396
Doi: 10.1038/tpj.2015.2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134
Doi: 10.1038/tpj.2013.15
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Emmert-Streib, F; de Matos Simoes, R; Glazko, G; McDade, S; Haibe-Kains, B; Holzinger, A; Dehmer, M; Campbell, F
Functional and genetic analysis of the colon cancer network.
BMC Bioinformatics. 2014; 15 Suppl 6(16):S6-S6
Doi: 10.1186/1471-2105-15-S6-S6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539
Doi: 10.1158/1535-7163.MCT-13-0646
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Páez, D; Gerger, A; Zhang, W; Yang, D; Labonte, MJ; Benhanim, L; Kahn, M; Lenz, F; Lenz, C; Ning, Y; Wakatsuki, T; Loupakis, F; Lenz, HJ
Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.
Pharmacogenomics J. 2014; 14(2):142-150
Doi: 10.1038/tpj.2013.20
Web of Science
PubMed
FullText
FullText_MUG
Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697
Doi: 10.1158/1078-0432.CCR-13-1517
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464
Doi: 10.1007/s00432-013-1461-x
Web of Science
PubMed
FullText
FullText_MUG
2012
Pitroda, SP; Zhou, T; Sweis, RF; Filippo, M; Labay, E; Beckett, MA; Mauceri, HJ; Liang, H; Darga, TE; Perakis, S; Khan, SA; Sutton, HG; Zhang, W; Khodarev, NN; Garcia, JG; Weichselbaum, RR
Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.
PLoS One. 2012; 7(10): e46104-e46104.
Doi: 10.1371/journal.pone.0046104
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Gerger, A; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Winder, T; LaBonte, MJ; Wilson, PM; Benhaim, L; Paez, D; El-Khoueiry, R; El-Khoueiry, A; Kahn, M; Lenz, HJ
Common cancer stem cell gene variants predict colon cancer recurrence.
Clin Cancer Res. 2011; 17(21):6934-6943
Doi: 10.1158/1078-0432.CCR-11-1180
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hallen, L; Klein, H; Stoschek, C; Wehrmeyer, S; Nonhoff, U; Ralser, M; Wilde, J; Röhr, C; Schweiger, MR; Zatloukal, K; Vingron, M; Lehrach, H; Konthur, Z; Krobitsch, S
The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2.
Hum Mol Genet. 2011; 20(1): 104-114.
Doi: 10.1093/hmg/ddq436
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jahn, SW; Winter, G; Stacher, E; Halbwedl, I; Gattenlöhner, S; Stockinger, R; Spreitzer, S; Waldispuehl-Geigl, J; Geigl, JB; Offner, F; Hoefler, G
Multiple intratumoral KRAS mutations can clonally segregate to different lymph node metastases in colon cancer.
Histopathology. 2011; 59(2): 342-345.
Doi: 10.1111/j.1365-2559.2011.03902.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Morselli, E; Shen, S; Ruckenstuhl, C; Bauer, MA; Mariño, G; Galluzzi, L; Criollo, A; Michaud, M; Maiuri, MC; Chano, T; Madeo, F; Kroemer, G
p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200.
Cell Cycle. 2011; 10(16):2763-2769
Doi: 10.4161/cc.10.16.16868
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Timmermann, B; Kerick, M; Roehr, C; Fischer, A; Isau, M; Boerno, ST; Wunderlich, A; Barmeyer, C; Seemann, P; Koenig, J; Lappe, M; Kuss, AW; Garshasbi, M; Bertram, L; Trappe, K; Werber, M; Herrmann, BG; Zatloukal, K; Lehrach, H; Schweiger, MR
Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis
PLOS ONE. 2010; 5(12): e15661-e15661.
Doi: 10.1371/journal.pone.0015661
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2009
Thalheimer, A; Otto, C; Bueter, M; Illert, B; Gattenlohner, S; Gasser, M; Fein, M; Germer, CT; Waaga-Gasser, AM
Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?
Eur Surg Res. 2009; 42(3):195-200
Doi: 10.1159/000205825
Web of Science
PubMed
FullText
FullText_MUG
2008
Sitić, S; Mirt-Dabić, M; Brcić, L; Juros, Z; Hutinec, Z; Kruslin, B
DNA ploidy in thymoma and associated multiple primary malignancies in the same patient.
Acta Clin Croat. 2008; 47(3):155-159
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
2004
Feilchenfeldt, J; Bründler, MA; Soravia, C; Tötsch, M; Meier, CA
Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1).
Cancer Lett. 2004; 203(1):25-33
Doi: 10.1016/j.canlet.2003.08.024
Web of Science
PubMed
FullText
FullText_MUG
2002
Bunz, F; Fauth, C; Speicher, MR; Dutriaux, A; Sedivy, JM; Kinzler, KW; Vogelstein, B; Lengauer, C
Targeted inactivation of p53 in human cells does not result in aneuploidy.
Cancer Res. 2002; 62(4):1129-1133
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
Vécsey-Semjén, B; Becker, KF; Sinski, A; Blennow, E; Vietor, I; Zatloukal, K; Beug, H; Wagner, E; Huber, LA
Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Oncogene. 2002; 21(30):4646-4662
Doi: 10.1038/sj.onc.1205577
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1997
Neumeister, P; Hoefler, G; Beham-Schmid, C; Schmidt, H; Apfelbeck, U; Schaider, H; Linkesch, W; Sill, H
Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas.
Gastroenterology. 1997; 112(6):1871-1875
Doi: 10.1053%2Fgast.1997.v112.pm9178679
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1988
Höfler, H
Oncogene expression in colonic cancers
Wien Med Wochenschr. 1988; 138(11-12):271-273
Web of Science
PubMed